禮來公司的 Foundayo（奧格列酮）是唯一一種無需限制食物或飲水即可服用的口服 GLP-1 受體激動劑，它與更年期各個階段女性的顯著體重減輕有關。
印第安納波利斯，2026年6月7日/PRNewswire/ -- Zepbound（替澤帕肽）的生產商禮來公司（NYSE：LLY）今日公佈的研究結果表明，服用最高劑量Foundayo的肥胖或超重女性患者出現了…
该文章暂未提取到完整正文，已从资讯列表和商品关联资讯中自动隐藏。你可以返回文章列表继续浏览其他内容。
Questions frequentes
Which products are related to this article?
No strongly related product has been identified yet. The match updates automatically when the article or catalog changes.
How can I view the medicines discussed in this article?
Use the related product cards below the article to review available specifications, prices, product information, and reviews.
Does this article replace advice from a doctor or pharmacist?
No. This content is for general information and health education only. Follow the prescription and individual guidance provided by qualified healthcare professionals.
